Programme Highlights

This is what you can look forward to at IMCC 2017 plenary sessions.


Children, teenagers and medical cannabis

The difference between a poison and a cure is in the dose – and in the availability.

Speakers: Ethan Russo, Tomáš Zábranský 


  • The difference of use of cannabis in adult medicine and in minors/underaged. Different dosage, frequency and amount of prescribed drug. Indications and their specifications.
  • The heated public debate and how to approach it to reach the ultimate objective: enable cannabis medicines to the most suitable patients and prohibit minors from misusing it for recreational purposes
  • Different legal approaches throughout the world, the situation in the most developed areas (North America, Europe). Review of state-of-art in medical studies on children’s medical cannabis use.

Cannabis in cancer treatment

Cannabis can help in many areas of most fearsome illness today. Can’t cure everything. But then, nothing can. 

Speakers: Alan Frankel, Jan Žaloudík 


  • Different areas of cannabis use in the cancer patients: pain treatment, nausea and vomiting, appetite loss. Cannabis as a neo-plastic agent – slowing down and stopping the growth of tumours?
  • Psychological aspects of medical cannabis in cancer patients. The use of psychoactive cannabis effects for the treatment of depression and coping with conditions with poor perspectives. 
  • The entourage effect – does the cannabis work better as a complex of different cannabinoids, or do we have to isolate, specify, measure and research each of the 100+ cannabis independently?

Change your legislation, persuade your politicians

Don’t be passive. They are politicians, they work for you – just tell them so. Get engaged!

Speakers: Michel Kazatchkine, Pavel Bém (Global Commission on Drug Policy) 


  • Five stages of transition between no medical cannabis and reasonable legislation, which allows access to cannabis with indicated patients: gathering the information, raising the awareness, organizing for action, creating the legal proposals, pushing the legislation through.
  • Four P’s of success: persistence, professionality, practice, propaganda (promotion)
  • Case study: introduction of medical cannabis in the Czech Republic. How the country went from rigid restrictive regime to generally available medical cannabis. What problems can a country encounter after the legalization (sub-legal norms).

Is EU a pasture for medical cannabis cash cows?

With unclaimed stakes in the cannabis territory and huge profit margins, there has never been a better time to invest.

Speakers: Ben Bronfman (Dioscorides), Mark Williams (Firefly, Apple)

Target Audience: Entrepreneurs, Startups
 
  • The booming business. Comparison of the numbers between US and EU. Higher GDP, more citizens, higher number of patients. No central law authority, which should eventually prohibit selling medical cannabis under regional laws.
  • The US experience in the EU – can it be repeated? The synergy between US experience and sources (personal, material) and EU practice (excellent local knowledge), network of contacts of suppliers, clients and general public.
  • Germany example. The biggest and leading European country will have legal cannabis from 2018, covered fully by insurance companies. The amount of cannabis needed will be huge. Where will they get it? What are the implications for other EU and US businesses?
  • Investor’s paradise. The returns of investment in the cannabis business are tremendous, and investors are already lining up to claim the best stakes.
  • EU market benefits: market size, legal stability, synergies and high returns

Educate your doctor. No one will do it for you

Doctor is no God. And no matter how many hours a patient spends online, googling doesn’t make him a doctor.

Speakers: Steph Sherer (ASA), Richard Rokyta

Area/ Tone: Activist
Target Audience: Patients with cannabis-treatable illnesses

  • The importance of mutual communication between doctors and their patients. Specification of roles in the healing process – doctor as an educated authority, patient as a respecting and respected human being.
  • Patient’s organisations and their work on national and global level. How to use the internet and social networks for sharing information in specific areas.
  • The educational role of the state and of individual. Why is it good to rely on the state and its certain operations in this field, and why is it wrong to give him a carte blanche.

Keep Me Updated